Should the Middle East be a priority launch market for orphan drug manufacturers?
Over the last few years, the Middle East has piqued the interest of orphan drug manufacturers, and some have prioritised launching in this region before European markets. Akshay Kumar and Lavni Varyani discuss what is driving this behaviour, the orphan drug infrastructure within the region, and opportunities, barriers, and key considerations for manufacturers aiming to launch in the Middle East.
Presenter: Akshay Kumar, Partner, P4A
Contributor: Lavni Varyani, Founder, Pharma Business Partners
Producer: Operations team
Create your
podcast in
minutes
It is Free